Nectar Lifesciences P/B Ratio
NECLIFE • Price-to-Book ratio analysis and book value breakdown
Current P/B Ratio
0.32
Low Valuation
Very Low - Significant discount to book value, potential distress or value opportunity
Current Valuation Metrics
P/B Ratio
0.32
Current Price
₹11.35
Book Value/Share
₹434.55
Exchange
NSE
Book Value Breakdown (2025)
Balance Sheet Components
Total Equity
₹956 Cr
Share Capital
₹22 Cr
Reserves & Surplus
₹934 Cr
Outstanding Shares
22,000,000
Book Value per Share
₹434.55
Valuation Signal
Signal
Undervalued
Historical Avg
0.06
Historical Range
0.05 - 0.08
Percentile
100.0%
Sector Context
Sector Average
-0.13
Sector Median
0.64
Sector Rank
#11 of 50
Sector Percentile
22.0%
Key P/B Ratio Insights for Nectar Lifesciences
- Stock appears undervalued with PB of 0.32, trading below book value
- Trading below book value - potential value opportunity or financial distress signal
- Current PB is 416.1% above historical average
- Trading at premium to sector average PB of -0.13
View the current stock price of Nectar Lifesciences for more insights.
P/B Ratio Historical Trend for Nectar Lifesciences
Historical P/B ratio trend based on balance sheet data. P/B below 1.0 may indicate undervaluation, while higher ratios suggest growth expectations or asset-light business models.
Related Pages for Nectar Lifesciences
Additional stock information and data for NECLIFE
Historical P/B Ratio Data
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2025 | 0.05 | ₹434.55 | ₹20.90 | ₹956 | Low |
| 2024 | 0.08 | ₹485.91 | ₹39.00 | ₹1,069 | Low |
| 2023 | 0.07 | ₹484.09 | ₹32.16 | ₹1,065 | Low |
| 2022 | 0.05 | ₹494.55 | ₹24.45 | ₹1,088 | Low |
| 2021 | 0.06 | ₹482.73 | ₹26.85 | ₹1,062 | Low |
Sector P/B Ratio Comparison
Comparing Nectar Lifesciences with other companies in Healthcare sector
Sector Average
-0.13
Sector Median
0.64
Lowest P/B
-11.38
Highest P/B
1.1
Companies
50
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Sun Pharma Advanced Rese… | SPARC | -11.38 | ₹4,036 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.47 | ₹95 | Low |
| Parmax Pharma | PARMAX | -2.15 | ₹12 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.96 | ₹154 | Low |
| Cresanto Global | CRESANTO | -0.67 | ₹2 | Low |
| Triochem Products | TRIPR | 0.04 | ₹0 | Low |